Cancer biotech Jounce Therapeutics has gotten a hostile takeover bid from Concentra Biosciences, a San Diego company backed by Tang Capital Partners. Tang Capital is also a shareholder in Jounce, owning just over 10% of its shares, which according to SEC documents were all purchased in the last two months.…
Jounce faces hostile takeover bid from minority stakeholder
